ConcertAI: ASCO 2024 study demonstrates that AI-based clinical trial screening is more than 3x faster than traditional methods

CAMBRIDGE, Mass., May 29, 2024 /PRNewswire/ — ConcertAI, the leader in oncology predictive and generative AI SaaS and Real-World Data (RWD) Solutions for clinical research, announced the results of the study being presented at ASCO 2024 showing that its Digital Trial Solutions (DTS)…